Epidemiology of COVID-19 and Predictors of Outcome in Nigeria: A Single-Center Study.
Adult
Aged
Asymptomatic Diseases
COVID-19
/ diagnosis
Cough
/ diagnosis
Creatinine
/ blood
Dyspnea
/ diagnosis
Female
Fever
/ diagnosis
Hospital Mortality
/ trends
Hospitalization
/ statistics & numerical data
Humans
Hypoxia
/ diagnosis
Male
Middle Aged
Nigeria
/ epidemiology
Pandemics
Prognosis
Retrospective Studies
Risk Factors
SARS-CoV-2
/ pathogenicity
Severity of Illness Index
Tertiary Care Centers
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
31
10
2020
medline:
17
12
2020
entrez:
30
10
2020
Statut:
ppublish
Résumé
There is a paucity of information regarding the epidemiology and outcome of COVID-19 from low/middle-income countries, including from Nigeria. This single-center study described the clinical features, laboratory findings, and predictors of in-hospital mortality of COVID-19 patients. Patients admitted between April 10, 2020 and June 10, 2020 were included. Forty-five patients with a mean age of 43 (16) years, predominantly male (87%), presented with fever (38%), cough (29%), or dyspnea (24%). In-hospital mortality was 16%. The independent predictors of mortality were hypoxemia (adjusted odds ratio [aOR]: 2.5; 95% CI: 1.3-5.1) and creatinine > 1.5 mg/dL (aOR: 4.3; 95% CI: 1.9-9.8).
Identifiants
pubmed: 33124545
doi: 10.4269/ajtmh.20-0759
pmc: PMC7695094
doi:
Substances chimiques
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2376-2381Références
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Nat Immunol. 2018 Dec;19(12):1299-1308
pubmed: 30374129
Travel Med Infect Dis. 2020 Mar - Apr;34:101623
pubmed: 32179124
Pan Afr Med J. 2020 May 06;35(Suppl 2):24
pubmed: 33623549
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
BMJ. 2020 May 22;369:m1966
pubmed: 32444366
Clin Chem Lab Med. 2020 Jul 28;58(8):1172-1181
pubmed: 32554832
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Pan Afr Med J. 2020 May 28;35(Suppl 2):53
pubmed: 33623578
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
J Clin Med. 2020 Mar 31;9(4):
pubmed: 32244365
Mayo Clin Proc. 2020 Jun;95(6):1138-1147
pubmed: 32376101
J Med Virol. 2020 Nov;92(11):2335-2337
pubmed: 32410212
Diagnosis (Berl). 2020 May 26;7(2):91-96
pubmed: 32352401
Clin Infect Dis. 2020 Jul 28;71(15):706-712
pubmed: 32109279
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759
pubmed: 32663409
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156327
BMC Med. 2020 Sep 3;18(1):270
pubmed: 32878619
J Am Soc Nephrol. 2020 Jul;31(7):1380-1383
pubmed: 32366514
J Med Virol. 2020 Jul;92(7):791-796
pubmed: 32181911
J Infect. 2020 Jun;80(6):656-665
pubmed: 32283155
Intensive Care Med. 2020 May;46(5):846-848
pubmed: 32125452
PLoS Pathog. 2020 Apr 28;16(4):e1008520
pubmed: 32343745
Scand J Clin Lab Invest. 2020 Oct;80(6):441-447
pubmed: 32449374
PLoS Pathog. 2011 Jul;7(7):e1002149
pubmed: 21829352
Am J Epidemiol. 2004 Feb 1;159(3):229-31
pubmed: 14742282
Eur Respir J. 2020 May 14;55(5):
pubmed: 32217650